市場調查報告書
商品編碼
1535042
輔助生殖技術醫療(ART)設備的全球市場 - 市場規模(各市場區隔),佔有率,法規,償付,治療,預測(~2033年)Assisted Reproductive Technology (ART) Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
本報告提供全球輔助生殖技術醫療(ART)設備市場相關調查分析,提供主要企業市場佔有率,主要趨勢,創新的產品與技術,競爭情形等資訊。
市場模式的主要內容如下列。
已上市的輔助生殖技術醫療(ART)設備與不斷變化的競爭格局
世界,地區,國家層級的市場固有的考察
透過對醫療保健系統的真實、全面的了解來促進市場理解。市場進入部分還提供有關報銷政策和監管環境的信息,使您能夠更深入地研究市場動態。
對象企業
Assisted Reproductive Technology (ART) Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Reproductive Health Devices therapeutic area.
ART refers to reproductive health procedures that treat subfertile or infertile women or men such that pregnancy is more likely achieved. Two prominent techniques analyzed in this market are in vitro fertilization (IVF) and intrauterine insemination (IUI).
Assisted Reproductive Technology (ART) refers to reproductive health procedures that help infertile women achieve pregnancy. For decades now across much of the developed world, several techniques of ART have been in use with varying pregnancy success rates. These techniques primarily include, but are not limited to, in vitro fertilization (IVF), intrauterine insemination (IUI), and to a lesser extent, gamete intrafallopian transfer (GIFT) and zygote intrafallopian transfer (ZIFT). Both female and male infertility are epidemiological factors that are considered when patients seek ART treatments. For women, these include tubal factors, ovulatory dysfunction, diminished ovarian reserves, endometriosis, among others. For men, male factor infertility is usually solely attricuted to poor sperm quality.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Assisted Reproductive Technology (ART) Devices and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Cook Medical Inc, CooperSurgical Inc, Corning Inc, FUJIFILM Irvine Scientific Inc, Vitrolife AB, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -